Below are the most recent publications written about "Graft Survival" by people in Profiles.
-
Reich DJ, Mao S, Satish S, Nassar A, Rizzari M, Al-Adra DP, DiNorcia J, Woloszyn J, Doyle MBM, Bohorquez H, Mihaylov P, Saharia A, Merani S, Wehrle CJ, Miller C, Axelrod D, Langnas A, Melcher ML, Akoad M, Ghobrial M, Kubal C, Roll G, Cohen A, Chapman WC, Pinna A, de Vera M, Florman S, Foley DP, Abouljoud M, Quintini C, Hashimoto K, Croome K, Taner CB, Schlegel A. Portal-Venous Hypothermic Oxygenated Perfusion for Liver Transplant: A Randomized Clinical Trial. JAMA Surg. 2026 07 01; 161(7):691-702.
-
Hasjim BJ, Rajan A, Saravanan N, Wu W, Kwong AJ, Mohamed K, Lim N, Cooper KM, Devuni D, Wang K, Shroff H, Tesfai K, Ajmera VH, Cheung A. Role of social determinants and outcomes of patients with alcohol-associated liver disease referred for early liver transplantation: A multicenter analysis. Am J Transplant. 2026 May; 26(5):1121-1132.
-
Anwar IJ, DeLaura I, Ladowski JM, Schilir? D, Gao Q, Manook M, Yoon J, Belloni R, Park A, Schuster DJ, Song M, Lin L, Farris AB, Magnani D, Williams K, Kwun J, Knechtle SJ. CD154 blockade effectively controls antibody-mediated rejection in highly sensitized nonhuman primate kidney transplant recipients. Sci Transl Med. 2025 Jan; 17(779):eadn8130.
-
Chutani A, Guevara-Pineda D, Lerner GB, Menon MC. Re-Evaluating the Transplant Glomerulopathy Lesion-Beyond Donor-Specific Antibodies. Transpl Int. 2024; 37:13365.
-
Halleck F, B?hmig GA, Couzi L, Rostaing L, Einecke G, Lefaucheur C, Legendre C, Montgomery R, Hughes P, Chandraker A, Wyburn K, Halloran P, Maldonado AQ, Sj?holm K, Runstr?m A, Lef?vre P, Tollemar J, Jordan S. A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody-Mediated Rejection. Clin Transplant. 2024 07; 38(7):e15383.
-
Faria I, Vidgren M, Canizares S, Devos L, Reichel K, Oniscu GC, Martins PN. Machine perfusion preservation highlights from the Congress of the European Society of Organ Transplantation 2023. Artif Organs. 2024 Jun; 48(6):686-691.
-
Long JJ, Motter JD, Jackson KR, Chen J, Orandi BJ, Montgomery RA, Stegall MD, Jordan SC, Benedetti E, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Verbesey JE, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Wellen JR, Bozorgzadeh A, Gaber AO, Heher EC, Weng FL, Djamali A, Helderman JH, Concepcion BP, Brayman KL, Oberholzer J, Kozlowski T, Covarrubias K, Massie AB, McAdams-DeMarco MA, Segev DL, Garonzik-Wang JM. Characterizing the risk of human leukocyte antigen-incompatible living donor kidney transplantation in older recipients. Am J Transplant. 2023 12; 23(12):1980-1989.
-
Bhat M, Dondossola D, Varghese R, Czigany Z, Emamaullee J, Ghinolfi D, Al-Adra D, Bonaccorsi-Riani E, Pang L, Boteon YL, Br?ggenwirth I, Pavan-Guimaraes J, Ho CM, Yuksel M, Zarrinpar A, Abdelrahim M, Barbas AS, Mas V, Selzner M, Martins PN. What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2022? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society. Transplantation. 2023 04 01; 107(4):808-814.
-
Bellini MI, Nozdrin M, Naesens M, Martins PN. Eliminating Race From eGFR Calculations: Impact on Living Donor Programs. Transpl Int. 2022; 35:10787.
-
Mikami T, Itagaki S, Fujisaki T, Kuno T, Lerner DP, Burns JD, Anyanwu AC. Association of Donor Brain Death Due to Stroke With Prognosis After Heart Transplantation. J Am Coll Cardiol. 2022 03 22; 79(11):1063-1072.